Suggested Topics within your search.
Suggested Topics within your search.
-
541
RNAcare: integrating clinical data with transcriptomic evidence using rheumatoid arthritis as a case study
Published 2025-05-01“…Users, including clinicians with a general knowledge of transcriptomics, however, who may have limited programming experience, are increasingly seeking tools that go beyond traditional analysis. To overcome these issues, computational tools must incorporate advanced techniques, such as machine learning, to better understand how gene expression correlates with patient symptoms of interest. …”
Get full text
Article -
542
Retour sur le volume « Le discours rapporté et l’expression de la subjectivité » (e-Rea 17.2, 2020)
Published 2023-12-01“…In the wake of the celebration of the 20th anniversary of the digital journal e-Rea, this paper aims to look back to issue number 17.2 entitled “Reported speech and the expression of subjectivity”, which was published in this journal in June 2020. …”
Get full text
Article -
543
-
544
Enhanced expression of full-length human cytomegalovirus fusion protein in non-swelling baculovirus-infected cells with a minimal fed-batch strategy.
Published 2014-01-01“…Human cytomegalovirus congenital infection represents an unmet medical issue and attempts are ongoing to develop an effective vaccine. …”
Get full text
Article -
545
-
546
Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Published 2015-01-01“…These data suggested that high TIMP-2 expression is associated with favorable prognosis in NSCLC. …”
Get full text
Article -
547
-
548
Real‐world first‐line treatment with pembrolizumab for non‐small cell lung carcinoma with high PD‐L1 expression: Updated analysis
Published 2024-07-01“…Abstract Background Selecting pembrolizumab monotherapy (MONO) or pembrolizumab plus platinum‐based chemotherapy (COMB) for patients with nonsmall cell lung cancer (NSCLC) and high programmed death‐ligand 1 (PD‐L1) expression is an important issue in clinical practice. …”
Get full text
Article -
549
Expression of immune checkpoints (IDO and PD-L1) in oral tongue cancer patients: a 10-year retrospective cohort study in Pakistan
Published 2025-08-01“…While PD-L1 expression was increased to 29.2% (n = 31), with 90.3% of the positive cases showing low expression and 9.7% high expression. …”
Get full text
Article -
550
-
551
-
552
-
553
The impact of microRNA-596 on oral cancer: Insights into tumor biology and treatment strategies
Published 2025-03-01Get full text
Article -
554
Les prénoms des élèves : une ressource didactique pour l’enseignant de français
Published 2024-06-01“…The aim of this research is to study the pedagogical effects of activities exploiting the symbolic dimension of pupils’ first names in French classes. The issue is as follows : how can the use of first names serve as a relevant didactic resource to enrich French language teaching ? …”
Get full text
Article -
555
Upregulation of long non-coding RNA ENSG00000267838 is related to the high risk of progression and non-response to chemoradiotherapy treatment for cervical cancer
Published 2025-04-01“…Statistical analysis correlated the expression profile of these lncRNAs with treatment efficacy. …”
Get full text
Article -
556
Specific Features of Ovarian Cancer Metastasis
Published 2020-12-01“…Since ovarian cancer is characterized by high mortality, mainly due to metastases, the issue of optimizing methods for predicting the treatment effectiveness depending on the cellular composition and expression of specific molecules in the milky spots of the greater omentum is urgent. …”
Get full text
Article -
557
-
558
-
559
MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer
Published 2024-03-01Get full text
Article -
560
SAP30, a novel autophagy regulatory gene in neuroblastoma
Published 2025-03-01Get full text
Article